Understanding Long-term Remission Off Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

INTRODUCTION: In antineutrophil cytoplasmic antibody-associated (ANCA) vasculitis, relapse risk and long-term immunosuppressive therapy are problematic. Stopping immunotherapy has not been well described. METHODS: The Glomerular Disease Collaborative Network ANCA vasculitis inception cohort was eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Hogan, Susan L., Nachman, Patrick H., Poulton, Caroline J., Hu, Yichun, Blazek, Lauren N., Free, Meghan E., Jennette, J. Charles, Falk, Ronald J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451087/
https://www.ncbi.nlm.nih.gov/pubmed/30993230
http://dx.doi.org/10.1016/j.ekir.2019.01.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451087/
https://www.ncbi.nlm.nih.gov/pubmed/30993230
http://dx.doi.org/10.1016/j.ekir.2019.01.004

Ejemplares similares